ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 2.03 USD 3.57% Market Closed
Market Cap: 196.3m USD
Have any thoughts about
ADC Therapeutics SA?
Write Note

Income Statement

Earnings Waterfall
ADC Therapeutics SA

Revenue
123.5m USD
Cost of Revenue
-7.1m USD
Gross Profit
116.4m USD
Operating Expenses
-380.6m USD
Operating Income
-264.2m USD
Other Expenses
-103m USD
Net Income
-367.2m USD

Income Statement
ADC Therapeutics SA

Rotate your device to view
Income Statement
Currency: USD
Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Revenue
Revenue
2
N/A
2
-15%
0
N/A
0
N/A
0
N/A
0
N/A
4
N/A
17
+350%
34
+100%
80
+137%
94
+17%
157
+67%
210
+34%
182
-13%
184
+1%
123
-34%
70
-43%
121
+75%
120
-2%
123
+3%
Gross Profit
Cost of Revenue
0
0
0
0
0
0
(0)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(2)
(2)
(3)
(6)
(7)
(7)
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
4
N/A
16
+348%
33
+100%
79
+142%
92
+17%
155
+69%
208
+34%
180
-13%
182
+1%
121
-34%
67
-44%
115
+72%
113
-2%
116
+3%
Operating Income
Operating Expenses
(122)
(138)
(157)
(177)
(219)
(246)
(282)
(300)
(302)
(318)
(322)
(329)
(329)
(311)
(285)
(257)
(233)
(392)
(379)
(381)
Selling, General & Administrative
(14)
(20)
(35)
(53)
(93)
(100)
(116)
(129)
(136)
(142)
(143)
(146)
(141)
(151)
(141)
(128)
(106)
(178)
(173)
(171)
Research & Development
(106)
(118)
(122)
(124)
(140)
(146)
(165)
(170)
(164)
(175)
(177)
(182)
(186)
(176)
(160)
(145)
(127)
(211)
(204)
(210)
Depreciation & Amortization
(2)
0
0
0
(2)
(0)
(1)
(1)
(3)
(2)
(1)
(1)
(2)
(1)
(1)
(2)
0
0
0
0
Other Operating Expenses
0
0
0
0
16
0
0
0
0
0
0
0
0
18
18
18
0
(2)
0
0
Operating Income
(119)
N/A
(136)
-14%
(157)
-15%
(177)
-12%
(219)
-24%
(246)
-12%
(278)
-13%
(284)
-2%
(270)
+5%
(240)
+11%
(230)
+4%
(174)
+24%
(121)
+31%
(131)
-8%
(103)
+21%
(137)
-33%
(166)
-21%
(277)
-67%
(266)
+4%
(264)
+1%
Pre-Tax Income
Interest Income Expense
2
2
(79)
(47)
(26)
(7)
71
26
10
13
19
24
8
(23)
(42)
(44)
(35)
(70)
(63)
(61)
Non-Reccuring Items
0
0
0
0
0
0
7
7
8
8
(1)
(41)
(42)
(43)
(41)
(2)
0
0
0
0
Total Other Income
2
2
0
(1)
(1)
(1)
1
0
0
0
0
0
0
0
1
1
6
4
4
4
Pre-Tax Income
(116)
N/A
(133)
-15%
(236)
-78%
(225)
+5%
(246)
-9%
(254)
-3%
(200)
+21%
(251)
-26%
(252)
0%
(218)
+13%
(211)
+3%
(191)
+10%
(155)
+19%
(197)
-27%
(185)
+6%
(182)
+2%
(195)
-8%
(343)
-75%
(325)
+5%
(321)
+1%
Net Income
Tax Provision
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(1)
22
23
24
25
(1)
(2)
4
3
(39)
(33)
(39)
(40)
Income from Continuing Operations
(117)
(133)
(237)
(226)
(246)
(254)
(200)
(252)
(230)
(195)
(187)
(166)
(156)
(199)
(181)
(179)
(235)
(375)
(364)
(360)
Equity Earnings Affiliates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(6)
(6)
(7)
(7)
Net Income (Common)
(117)
N/A
(133)
-15%
(237)
-77%
(226)
+5%
(246)
-9%
(254)
-3%
(200)
+21%
(252)
-26%
(230)
+9%
(195)
+15%
(187)
+4%
(166)
+11%
(156)
+6%
(199)
-27%
(181)
+9%
(179)
+2%
(240)
-34%
(382)
-59%
(371)
+3%
(367)
+1%
EPS (Diluted)
-1.52
N/A
-1.88
-24%
-3.34
-78%
-2.94
+12%
-3.21
-9%
-3.31
-3%
-2.61
+21%
-3.28
-26%
-3
+9%
-2.55
+15%
-2.44
+4%
-2.11
+14%
-1.99
+6%
-2.45
-23%
-2.22
+9%
-2.17
+2%
-2.94
-35%
-4.62
-57%
-3.87
+16%
-3.5
+10%

See Also

Discover More